glp-1 ra Glucagon-like peptide-1 Emerging Trends in the Development
Description
As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide mimics the action of the GLP-1 hormone in the body
A 2,700-person study out of Denmark saw an average of 16% body weight loss at 64 weeks for the 20% of the participants who remained at microdose levels for the duration of the study
rather, it reflects how strongly GLP-1 receptors affect gastric emptying and gut motility before the body has time to adapt
PIONEER 9 investigators
We further explored potential drug interactions between GLP-1RAs and neuropsychiatric drugs by performing an shrinkage analysis
